Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec 30:18:3067-3071.
doi: 10.2147/NDT.S393553. eCollection 2022.

Biological Diagnosis of Depression: A Biomarker Panel from Several Nonspecial Indicators Instead of the Specific Biomarker(s)

Jia-Mei Li  1   2 , Chun-Lei Jiang  1
Affiliations

Biological Diagnosis of Depression: A Biomarker Panel from Several Nonspecial Indicators Instead of the Specific Biomarker(s)

Jia-Mei Li et al. Neuropsychiatr Dis Treat. .

Abstract

It is a consensus that the diagnosis efficiency of depression is rather low in clinic. The traditional way of diagnosing depression by symptomatology is flawed. Recent years, a growing body of evidence has underlined the importance of physiological indicators in the diagnosis of depression. However, the diagnosis of depression is difficult to be like some common clinical diseases, which have clear physiological indicators. A single physiological index provides limited information to clinicians and is of little help in the diagnosis of depression. Thus, it is more rational and practical to diagnose depression with a biomarker panel, which covers a few non-specific indicators, such as hormones, cytokines, and neurotrophins. This open review suggested that biomarker panel had a bright future in creating a new model of depression diagnosis or at least providing a reference to the existing depression criteria. The viewpoint is also the future of other psychiatric diagnosis.

Keywords: biological diagnosis; biomarker; depression; nonspecial indicator; panel.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

References

    1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. fifth ed. American Psychiatric Association; 2013.
    1. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 11th Revision. World Health Organization; 2018.
    1. Regier DA, Narrow WE, Clarke DE, et al. DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnoses. Am J Psychiatry. 2013;170(1):59–70. doi:10.1176/appi.ajp.2012.12070999 - DOI - PubMed
    1. Fried EI, Epskamp S, Nesse RM, Tuerlinckx F, Borsboom D. What are ‘good’ depression symptoms? Comparing the centrality of DSM and non-DSM symptoms of depression in a network analysis. J Affect Disord. 2016;189:314–320. doi:10.1016/j.jad.2015.09.005 - DOI - PubMed
    1. Snyder R, Liebman LS, Simon AB, Kellner CH. Does heterogeneity of depression diagnosis harm those with severe mood disorders? Med Hypotheses. 2013;81(2):316–318. doi:10.1016/j.mehy.2013.04.011 - DOI - PubMed

LinkOut - more resources